Position in VRTX
as of Mar 31, 2026
· filed May 14, 2026
Position Value
$15,790,100
-$28,602,911 QoQ
Shares Held
35,361
-63.9% QoQ
Ownership
0.014%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in VRTX Over Time
Shares Held
Position Value (USD)
Derivatives in VRTX
reported options exposure · as of Mar 31, 2022CallValue
$0
CallShares
0
PutValue
$8,354,954
PutShares
32,015
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Mar 31, 2026BANK OF NOVA SCOTIA holds $148,137,503 across 17 Biotechnology names. VRTX ranks #3 (10.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
97,520 | $75,347,852 | |
| 2 | ROIV |
Roivant Sciences Ltd.
|
1,310,387 | $36,297,719 | |
| 3 | VRTX |
Vertex Pharmaceuticals Inc / Ma
This page
|
35,361 | $15,790,100 | |
| 4 | ARWR |
Arrowhead Pharmaceuticals, Inc.
|
135,960 | $8,524,692 | |
| 5 | INCY |
Incyte Corp
|
27,500 | $2,588,300 | |
| 6 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
7,798 | $2,580,124 | |
| 7 | INSM |
INSMED Inc
|
15,203 | $2,485,994 | |
| 8 | ANTX |
AN2 Therapeutics, Inc.
|
459,194 | $1,570,443 |
All Filings in VRTX
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $15,790,100 | 35,361 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $44,393,011 | 97,920 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $33,779,733 | 86,252 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $22,085,926 | 49,609 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $13,423,696 | 27,688 | Shares | Defined | 2025-07-02 | |
| 2024-12-31 | $18,965,961 | 47,097 | Shares | Sole | 2025-07-02 | |
| 2024-09-30 | $34,727,523 | 74,670 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $24,076,739 | 51,367 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $94,443,505 | 225,936 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $25,368,369 | 62,347 | Shares | Defined | 2024-02-12 | |
| 2023-09-30 | $20,503,791 | 58,963 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $8,805,139 | 25,021 | Shares | Defined | 2023-08-03 | |
| 2023-03-31 | $7,357,197 | 23,351 | Shares | Defined | 2023-05-11 | |
| 2022-12-31 | $12,321,664 | 42,668 | Shares | Sole | 2023-02-09 | |
| 2022-09-30 | $9,765,025 | 33,726 | Shares | Defined | 2022-11-10 | |
| 2022-06-30 | $18,324,239 | 65,028 | Shares | Defined | 2022-08-11 | |
| 2022-03-31 | $11,346,452 | 43,478 | Shares | Defined | 2022-05-09 | |
| 2022-03-31 | $8,354,954 | 32,015 | Put | Defined | 2022-05-09 | |
| 2021-12-31 | $22,236,475 | 101,259 | Shares | Defined | 2022-02-11 | |
| 2021-09-30 | $88,601,576 | 488,459 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $8,251,102 | 40,922 | Shares | Defined | 2021-08-12 | |
| 2021-03-31 | $10,865,697 | 50,564 | Shares | Defined | 2021-05-06 | |
| 2020-12-31 | $28,370,489 | 120,041 | Shares | Sole | 2021-02-11 | |
| 2020-09-30 | $25,496,827 | 93,697 | Shares | Defined | 2020-11-12 | |
| 2020-06-30 | $120,940,242 | 416,590 | Shares | Defined | 2020-08-11 | |
| 2020-03-31 | $86,367,283 | 362,964 | Shares | Defined | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||